| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.7 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |